Abstract:Background: In recent years, long non-coding RNAs (lncRNAs) have been shown to play a critical regulatory role in cancer biology. However, the contribution of lncRNAs to papillary thyroid cancer (PTC) remains largely unknown. Methods: RNA sequencing and quantitative reverse transcription polymerase chain reaction were used to detect and verify changes to the transcriptome profile in 12 PTC tissues compared to paired normal adjacent tissues. The statistical correlation between differentially expressed lncRNAs and clinicopathologic characteristics was analyzed, and potential lncRNA functions were predicted by examining annotations for the co-expressed mRNAs. Furthermore, the specific subgroup patterns of the PTC transcriptome remodeled by BRAF mutations were also analyzed. Results: A total of 188 lncRNAs and 505 mRNAs were differentially expressed in 50% or more of the PTC tissues (fold change >2; p<0.05) as assessed by RNA-sequencing compared with paired normal adjacent tissues. Forty-seven lncRNAs and 39 mRNAs were verified in 31 pairs of PTC specimens using quantitative reverse transcription polymerase chain reaction, and the results were consistent with the RNA sequencing data. The lncRNAs NONHSAT076747 and NONHSAT122730 were associated with lymph node metastasis, and NONHSAG051968 expression was negatively correlated with tumor size. A co-expression network between differentially expressed lncRNAs and protein-coding RNAs was constructed and analyzed, and functional analysis suggested that the differentially expressed genes mainly participate in ECM-receptor interactions and the focal adhesion pathway. Furthermore, a specific PTC transcriptome subtype pattern stratified by BRAF mutation was also uncovered. The p53 signaling pathway was the most highly enriched pathway among the BRAF mutation-related genes. Conclusions: This study reveals specific changes to the lncRNA profile associated with PTC, and provides new insight into its pathogenesis. The PTC-associated lncRNAs NONHSAG051968, NONHSAT076747, and NONHSAT122730 might be potential diagnostic and therapeutic targets for PTC patients, and lncRNAs with subtype-specific expression stratified by BRAF mutation might be significant in individual molecular subtypes.

A Long Non-Coding RNA, PTCSC3, As a Tumor Suppressor and a Target of Mirnas in Thyroid Cancer Cells

Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer

MicroRNA-203a-3p may prevent the development of thyroid papillary carcinoma via repressing MAP3K1 and activating autophagy

Long Noncoding RNA CNALPTC1 Promotes Cell Proliferation and Migration of Papillary Thyroid Cancer Via Sponging Mir-30 Family.

Suppression Of Long Noncoding Rna Linc00324 Restricts Cell Proliferation And Invasion Of Papillary Thyroid Carcinoma Through Downreguiation Of Trim29 Via Upregulating Microrna-195-5p

LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis

Long Noncoding RNA Papillary Thyroid Carcinoma Susceptibility Candidate 3 (PTCSC3) Inhibits Proliferation and Invasion of Glioma Cells by Suppressing the Wnt/β-catenin Signaling Pathway.

Downregulation of TSPAN13 by Mir-369-3p Inhibits Cell Proliferation in Papillary Thyroid Cancer (PTC)

LncRNA PVT1 Acts As a Tumor Promoter in Thyroid Cancer and Promotes Tumor Progression by Mediating Mir-423-5p-pak3

MicroRNA-363-3p Inhibits Papillary Thyroid Carcinoma Progression by Targeting PIK3CA.

Long Non‑coding RNA PTCSC3 Suppresses Triple‑negative Breast Cancer by Downregulating Long Non‑coding RNA MIR100HG

Suppression of CCT3 Inhibits Malignant Proliferation of Human Papillary Thyroid Carcinoma Cell

A Novel Lncrna N384546 Promotes Thyroid Papillary Cancer Progression and Metastasis by Acting As a Competing Endogenous RNA of Mir-145-5p to Regulate AKT3

MiR-137 Acts As a Tumor Suppressor in Papillary Thyroid Carcinoma by Targeting CXCL12.

Mir-153-3p Suppresses Cell Proliferation, Invasion And Glycolysis Of Thyroid Cancer Through Inhibiting E3f3 Expression

The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2

Ott_a_267887 519..529

Integrated Analysis of Long Noncoding RNA Interactions Reveals the Potential Role in Progression of Human Papillary Thyroid Cancer.

Silencing of Lncrna LINC00514 Inhibits the Malignant Behaviors of Papillary Thyroid Cancer Through Mir-204-3p/cdc23 Axis.

Long Noncoding RNA UCA1 Promotes Proliferation and Metastasis of Thyroid Cancer Cells by Sponging Mir-497-3p.

Long Noncoding RNA LINC003121 Inhibits Proliferation and Invasion of Thyroid Cancer Cells by Suppression of the Phosphatidylinositol-3-Kinase (pi3k)/akt Signaling Pathway